Simergent
Chicago, US · Delaware LLC · 3 known investors
Simergent develops medical device systems for regulated healthcare markets, with expertise in peritoneal dialysis and infusion pump technologies. The company is led by engineers with FDA clearance experience and clinical advisory from nephrologists.
Founders & leadership
SJ
Steve J. LindoCo-founder & CEO
RP
Rick PendergraftCo-founder & Chief Technology Officer
DJ
Dr. James SloandChief Medical Officer
MR
Michael RohlederManager
Investors · 3
Reported raises · per SEC filings
Form D private placements▶$8.8MraisedMar 2026 · 57 investors · BiotechnologyRule 506(b)
▶$8.8MraisedMar 2026 · 57 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael RohlederExecutive Officer, Director
- Rick PendergraftExecutive Officer, Director
- Steve J LindoExecutive Officer, Director
- Offering amount
- $9.9M
- Amount sold
- $8.8M
- Minimum investment
- $18.4K
- First sale
- Mar 2024
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.